Inducible cyclooxygenase may have anti-inflammatory properties - PubMed (original) (raw)
Inducible cyclooxygenase may have anti-inflammatory properties
D W Gilroy et al. Nat Med. 1999 Jun.
Abstract
Cyclooxygenase (COX) has two isoforms. Generally, COX 1 is constitutively expressed in most tissues, where it maintains physiological processes; inducible COX 2 is considered a pro-inflammatory enzyme and a chief target for the treatment of inflammatory diseases. Here we present evidence that COX 2 may have anti-inflammatory properties. In carrageenin-induced pleurisy in rats, the predominant cells at 2 hours are polymorphonuclear leucocytes, whereas mononuclear cells dominate from 24 hours until resolution at 48 hours. In this model, COX 2 protein expression peaked initially at 2 hours, associated with maximal prostaglandin E2 synthesis. However, at 48 hours there was a second increase in COX 2 expression, 350% greater than that at 2 hours. Paradoxically, this coincided with inflammatory resolution and was associated with minimal prostaglandin E2 synthesis. In contrast, levels of prostaglandin D2, and 15deoxy delta(12-14)prostaglandin J2 were high at 2 hours, decreased as inflammation increased, but were increased again at 48 hours. The selective COX 2 inhibitor NS-398 and the dual COX 1/COX 2 inhibitor indomethacin inhibited inflammation at 2 hours but significantly exacerbated inflammation at 48 hours. This exacerbation was associated with reduced exudate prostaglandin D2 and 15deoxy delta(12-14)prostaglandin J2 concentrations, and was reversed by replacement of these prostaglandins. Thus, COX 2 may be pro-inflammatory during the early phase of a carrageenin-induced pleurisy, dominated by polymorphonuclear leucocytes, but may aid resolution at the later, mononuclear cell-dominated phase by generating an alternative set of anti-inflammatory prostaglandins.
Comment in
- COX-2 inhibitors--is there cause for concern?
Seibert K, Lefkowith J, Tripp C, Isakson P, Needleman P. Seibert K, et al. Nat Med. 1999 Jun;5(6):621-2. doi: 10.1038/9465. Nat Med. 1999. PMID: 10371498 No abstract available.
Similar articles
- Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.
Ghosh AK, Hirasawa N, Niki H, Ohuchi K. Ghosh AK, et al. J Pharmacol Exp Ther. 2000 Nov;295(2):802-9. J Pharmacol Exp Ther. 2000. PMID: 11046121 - Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
Oka T, Shearer T, Azuma M. Oka T, et al. Curr Eye Res. 2004 Jul;29(1):27-34. doi: 10.1080/02713680490513164. Curr Eye Res. 2004. PMID: 15370364 - Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J, Bonior J, Tomaszewska R, Jachimczak B, Kot M, Bielański W, Pawlik WW, Sendur R, Stachura J, Konturek PC, Konturek SJ. Jaworek J, et al. J Physiol Pharmacol. 2001 Mar;52(1):107-26. J Physiol Pharmacol. 2001. PMID: 11321505 - [New NSAIDS: COX-1, COX-2, what about them?].
Peretz A. Peretz A. Rev Med Brux. 1998 Sep;19(4):A399-402. Rev Med Brux. 1998. PMID: 9805982 Review. French. - Cox-2-selective inhibitors: the new super aspirins.
DeWitt DL. DeWitt DL. Mol Pharmacol. 1999 Apr;55(4):625-31. Mol Pharmacol. 1999. PMID: 10101019 Review. No abstract available.
Cited by
- Targeting inflammation in metabolic syndrome.
Welty FK, Alfaddagh A, Elajami TK. Welty FK, et al. Transl Res. 2016 Jan;167(1):257-80. doi: 10.1016/j.trsl.2015.06.017. Epub 2015 Jul 3. Transl Res. 2016. PMID: 26207884 Free PMC article. Review. - Inflammation modulates expression of laminin in the central nervous system following ischemic injury.
Ji K, Tsirka SE. Ji K, et al. J Neuroinflammation. 2012 Jul 3;9:159. doi: 10.1186/1742-2094-9-159. J Neuroinflammation. 2012. PMID: 22759265 Free PMC article. - Multifaceted roles of PGE2 in inflammation and cancer.
Nakanishi M, Rosenberg DW. Nakanishi M, et al. Semin Immunopathol. 2013 Mar;35(2):123-37. doi: 10.1007/s00281-012-0342-8. Epub 2012 Sep 21. Semin Immunopathol. 2013. PMID: 22996682 Free PMC article. Review. - Carcinogenesis: Failure of resolution of inflammation?
Fishbein A, Hammock BD, Serhan CN, Panigrahy D. Fishbein A, et al. Pharmacol Ther. 2021 Feb;218:107670. doi: 10.1016/j.pharmthera.2020.107670. Epub 2020 Sep 3. Pharmacol Ther. 2021. PMID: 32891711 Free PMC article. Review. - PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.
Kong D, Shen Y, Liu G, Zuo S, Ji Y, Lu A, Nakamura M, Lazarus M, Stratakis CA, Breyer RM, Yu Y. Kong D, et al. J Exp Med. 2016 Sep 19;213(10):2209-26. doi: 10.1084/jem.20160459. Epub 2016 Sep 12. J Exp Med. 2016. PMID: 27621415 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous